Common Stock, Shares, Outstanding of scPharmaceuticals Inc. from 31 Dec 2017 to 30 Jun 2025

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
scPharmaceuticals Inc. quarterly Common Stock, Shares, Outstanding in shares history and change rate from 31 Dec 2017 to 30 Jun 2025.
  • scPharmaceuticals Inc. Common Stock, Shares, Outstanding for the quarter ending 30 Jun 2025 was 53,290,227, a 47% increase year-over-year.
Source SEC data
View on sec.gov
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Change (%)

scPharmaceuticals Inc. Quarterly Common Stock, Shares, Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q2 2025 53,290,227 +17,150,425 +47% 30 Jun 2025 10-Q 07 Aug 2025 2025 Q2
Q1 2025 50,283,925 +14,229,516 +39% 31 Mar 2025 10-Q 14 May 2025 2025 Q1
Q4 2024 50,095,689 +14,127,179 +39% 31 Dec 2024 10-Q 07 Aug 2025 2025 Q2
Q3 2024 50,040,134 +14,181,089 +40% 30 Sep 2024 10-Q 13 Nov 2024 2024 Q3
Q2 2024 36,139,802 +290,320 +0.81% 30 Jun 2024 10-Q 14 Aug 2024 2024 Q2
Q1 2024 36,054,409 +285,336 +0.8% 31 Mar 2024 10-Q 14 May 2024 2024 Q1
Q4 2023 35,968,510 +1,710,594 +5% 31 Dec 2023 10-K 19 Mar 2025 2024 FY
Q3 2023 35,859,045 +8,456,924 +31% 30 Sep 2023 10-Q 08 Nov 2023 2023 Q3
Q2 2023 35,849,482 +8,454,336 +31% 30 Jun 2023 10-Q 10 Aug 2023 2023 Q2
Q1 2023 35,769,073 +8,397,585 +31% 31 Mar 2023 10-Q 10 May 2023 2023 Q1
Q4 2022 34,257,916 +6,891,209 +25% 31 Dec 2022 10-K 13 Mar 2024 2023 FY
Q3 2022 27,402,121 +46,667 +0.17% 30 Sep 2022 10-Q 09 Nov 2022 2022 Q3
Q2 2022 27,395,146 +39,692 +0.14% 30 Jun 2022 10-Q 09 Aug 2022 2022 Q2
Q1 2022 27,371,488 +16,035 +0.06% 31 Mar 2022 10-Q 16 May 2022 2022 Q1
Q4 2021 27,366,707 +40,748 +0.15% 31 Dec 2021 10-K 22 Mar 2023 2022 FY
Q3 2021 27,355,454 +34,995 +0.13% 30 Sep 2021 10-Q 09 Nov 2021 2021 Q3
Q2 2021 27,355,454 +67,457 +0.25% 30 Jun 2021 10-Q 11 Aug 2021 2021 Q2
Q1 2021 27,355,453 +6,373,573 +30% 31 Mar 2021 10-Q 12 May 2021 2021 Q1
Q4 2020 27,325,959 +7,907,004 +41% 31 Dec 2020 10-K 22 Mar 2022 2021 FY
Q3 2020 27,320,459 +8,690,729 +47% 30 Sep 2020 10-Q 16 Nov 2020 2020 Q3
Q2 2020 27,287,997 +8,707,567 +47% 30 Jun 2020 10-Q 13 Aug 2020 2020 Q2
Q1 2020 20,981,880 +2,401,450 +13% 31 Mar 2020 10-Q 12 May 2020 2020 Q1
Q4 2019 19,418,955 +849,666 +4.6% 31 Dec 2019 10-K 23 Mar 2021 2020 FY
Q3 2019 18,629,730 +60,441 +0.32% 30 Sep 2019 10-Q 12 Nov 2019 2019 Q3
Q2 2019 18,580,430 +11,141 +0.06% 30 Jun 2019 10-Q 07 Aug 2019 2019 Q2
Q1 2019 18,580,430 +38,218 +0.21% 31 Mar 2019 10-Q 08 May 2019 2019 Q1
Q4 2018 18,569,289 +35,049 +0.19% 31 Dec 2018 10-K 24 Mar 2020 2019 FY
Q3 2018 18,569,289 30 Sep 2018 10-Q 13 Nov 2018 2018 Q3
Q2 2018 18,569,289 30 Jun 2018 10-Q 14 Aug 2018 2018 Q2
Q1 2018 18,542,212 31 Mar 2018 10-Q 07 May 2018 2018 Q1
Q4 2017 18,534,240 31 Dec 2017 10-K 21 Mar 2019 2018 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.